Published in Cancer Weekly, August 5th, 2003
"This is a landmark study that may have a profound impact on the care for a large number of women with ovarian cancer," said Maurie Markman, MD, chairman of the Department of Hematology/Medical Oncology at the Cleveland Clinic, and lead author of the study. "Our findings show, for the first time, that we can significantly increase the amount of time that patients live free from disease, an important goal of anti-cancer therapy."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.